LakeShore Biopharma Co Net Income

LakeShore Biopharma Co posts a net income of $-430M as of March 2024. That is below the sector sector average of $130M. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a net income near $130M is typical. LakeShore Biopharma Co's $-430M is lower that level. That is roughly 430.4% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Net Income is one piece of LakeShore Biopharma Co's financial statement story. At $-430M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for YS's net income usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $130M), and (3) consistency with growth and profitability. This page covers the first two; LakeShore Biopharma Co's other metric pages and overview cover the third.